June, 04 2026 Thursday 09:33 Hrs
Last update 11-9-2025
  • SENSEX :   74,095.83

  • Top commodity trading and broking companies in India-250.34( -0.34%) 04-Jun-2026
Negative
Sensex 74125.15 -221.02  (-0.30) 04-Jun-2026
Previous Day Close 74346.17
Today's High/Low
High Low
  •  
  •  
74229.8 73807.3

Company News Details

Novelix Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
536565
INE314I01036
21.8058171
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
50.8
129.89
EPS(TTM)
Face Value()
Div & Yield %
1.07
10
0
 

novelix pharmaceuticals ltd
Novelix Pharmaceuticals standalone net profit rises 405.56% in the March 2026 quarter
May 30,2026
Net profit of Novelix Pharmaceuticals rose 405.56% to Rs 0.91 crore in the quarter ended March 2026 as against Rs 0.18 crore during the previous quarter ended March 2025. Sales rose 20.76% to Rs 25.19 crore in the quarter ended March 2026 as against Rs 20.86 crore during the previous quarter ended March 2025.

For the full year,net profit rose 3100.00% to Rs 2.56 crore in the year ended March 2026 as against Rs 0.08 crore during the previous year ended March 2025. Sales rose 330.70% to Rs 132.31 crore in the year ended March 2026 as against Rs 30.72 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales25.1920.86 21 132.3130.72 331
OPM %5.081.10 -2.630.46 -
PBDT1.280.23 457 3.510.16 2094
PBT1.230.21 486 3.410.12 2742
NP0.910.18 406 2.560.08 3100
Top

Attention Investor:

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.